Xcout Intel
Star Therapeutics
Star Therapeutics is a biotechnology company that discovers and develops antibody therapies to treat patients with serious diseases. The company focuses on creating patient-centric medical solutions to address real-world healthcare needs.
Subscribe to see Star Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Star Therapeutics at a glance
Star Therapeutics is a biotechnology company headquartered in United States. It has raised at least $215M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Series D, raised $125M in September 2025. Xcout tracks 18 named people at Star Therapeutics, including Adam Rosenthal, PhD (Chief Executive Officer).
Star Therapeutics leadership
- Adam Rosenthal, PhDChief Executive Officer
- Scott RobertsonCBO and CFO
- Nancy StaglianoExecutive Chair
- Adam Rosenthal, PhDCEO and Founder
- Sandip Panicker, PhDCSO
- Monica KamioVP, Head of Human Resources
12 more named people on record for Star Therapeutics, with roles, board committees and tenure — see the full roster →
Star Therapeutics funding rounds
At least $215M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $125M | 14 named | |
| Series D | Undisclosed | 14 named | |
| Series D | $90M | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Star Therapeutics competitors
A few of Star Therapeutics's closest competitors — see the full list of competitors and alternatives →
Northern Biologics is a biotechnology company developing antibody-based therapeutics, with a focus on treating cancer and targeting the tumor microenvironment. Its products are intended for oncology patients and clinical partners in the biopharmaceutical sector.
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Starton Therapeutics is a clinical-stage biotechnology company that develops proprietary continuous delivery technology systems to improve standard-of-care cancer therapies. The company utilizes subcutaneous, oral, and transdermal delivery platforms to transform FDA-approved active ingredients for superior patient outcomes.
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Electra Therapeutics is a biopharmaceutical company focused on developing first-in-class antibody therapies targeting signal regulatory proteins (SIRP) for immunological and oncological diseases.
Crossbow Therapeutics is a privately held biotechnology company founded in 2021 and headquartered in Cambridge, Massachusetts. The company develops potent antibody therapeutics aimed at expanding treatment options and combating cancer.
Get Star Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Star Therapeutics in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access